FWM
ABBV icon

Focused Wealth Management’s AbbVie ABBV Stock Holding History

Focused Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
9,724
+362
+4% +$77.9K 0.21% 55
2026
Q1 		$2.04M Buy
9,362
+793
+9% +$176K 0.21% 52
2025
Q4 		$1.96M Buy
8,569
+142
+2% +$32.3K 0.2% 51
2025
Q3 		$1.95M Buy
8,427
+501
+6% +$102K 0.21% 54
2025
Q2 		$1.47M Buy
7,926
+270
+4% +$50.2K 0.18% 55
2025
Q1 		$1.6M Buy
7,656
+1,905
+33% +$370K 0.22% 48
2024
Q4 		$1.02M Sell
5,751
-490
-8% -$90.1K 0.14% 59
2024
Q3 		$1.23M Buy
6,241
+25
+0.4% +$4.67K 0.16% 66
2024
Q2 		$1.07M Sell
6,216
-89
-1% -$14.7K 0.15% 61
2024
Q1 		$1.15M Buy
6,305
+211
+3% +$36.4K 0.18% 57
2023
Q4 		$944K Buy
6,094
+167
+3% +$24.3K 0.16% 58
2023
Q3 		$883K Buy
5,927
+84
+1% +$12.3K 0.16% 57
2023
Q2 		$787K Sell
5,843
-208
-3% -$30.5K 0.14% 64
2023
Q1 		$964K Buy
6,051
+206
+4% +$31.5K 0.2% 51
2022
Q4 		$945K Buy
5,845
+2,479
+74% +$380K 0.19% 57
2022
Q3 		$452K Buy
3,366
+303
+10% +$43.5K 0.09% 82
2022
Q2 		$469K Sell
3,063
-187
-6% -$28.6K 0.09% 85
2022
Q1 		$527K Buy
3,250
+17
+0.5% +$2.47K 0.08% 89
2021
Q4 		$438K Buy
3,233
+21
+0.7% +$2.48K 0.07% 106
2021
Q3 		$346K Buy
3,212
+211
+7% +$24.1K 0.06% 119
2021
Q2 		$338K Buy
3,001
+18
+0.6% +$2.03K 0.06% 123
2021
Q1 		$323K Buy
2,983
+218
+8% +$23.3K 0.06% 126
2020
Q4 		$296K Sell
2,765
-52
-2% -$5K 0.06% 123
2020
Q3 		$247K Sell
2,817
-1,259
-31% -$119K 0.05% 128
2020
Q2 		$400K Buy
4,076
+2,487
+157% +$219K 0.09% 90
2020
Q1 		$121K Buy
1,589
+60
+4% +$5.11K 0.03% 168
2019
Q4 		$135K Sell
1,529
-42
-3% -$3.49K 0.03% 217
2019
Q3 		$119K Buy
1,571
+9
+0.6% +$617 0.03% 212
2019
Q2 		$114K Sell
1,562
-123
-7% -$9.67K 0.03% 221
2019
Q1 		$136K Buy
1,685
+6
+0.4% +$491 0.04% 173
2018
Q4 		$155K Buy
1,679
+256
+18% +$22.5K 0.05% 161
2018
Q3 		$135K Buy
1,423
+1
+0.1% +$95 0.05% 197
2018
Q2 		$132K Buy
1,422
+5
+0.4% +$488 0.05% 200
2018
Q1 		$134K Buy
1,417
+5
+0.4% +$549 0.04% 213
2017
Q4 		$137K Sell
1,412
-805
-36% -$75.9K 0.04% 198
2017
Q3 		$197K Buy
2,217
+815
+58% +$62K 0.07% 121
2017
Q2 		$102K Buy
1,402
+3
+0.2% +$202 0.04% 220
2017
Q1 		$91K Sell
1,399
-400
-22% -$25.1K 0.04% 223
2016
Q4 		$113K Sell
1,799
-248
-12% -$15.1K 0.05% 210
2016
Q3 		$129K Sell
2,047
-98
-5% -$6.34K 0.06% 192
2016
Q2 		$133K Sell
2,145
-47
-2% -$2.86K 0.06% 185
2016
Q1 		$125K Buy
2,192
+274
+14% +$15.3K 0.07% 128
2015
Q4 		$114K Buy
1,918
+83
+5% +$4.78K 0.07% 139
2015
Q3 		$100K Buy
1,835
+3
+0.2% +$195 0.06% 143
2015
Q2 		$123K Buy
1,832
+85
+5% +$5.55K 0.08% 120
2015
Q1 		$102K Buy
1,747
+179
+11% +$10.8K 0.06% 141
2014
Q4 		$103K Buy
1,568
+1
+0.1% +$63 0.07% 127
2014
Q3 		$91K Buy
1,567
+302
+24% +$16.8K 0.07% 141
2014
Q2 		$71K Buy
1,265
+1
+0.1% +$52 0.06% 160
2014
Q1 		$65K Buy
1,264
+2
+0.2% +$101 0.05% 156
2013
Q4 		$67K Buy
1,262
+1
+0.1% +$49 0.06% 151
2013
Q3 		$56K Buy
+1,261
New +$55.9K 0.05% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Focused Wealth Management's ABBV Position: Q2 2026 in Review

Focused Wealth Management increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $77.9K and bringing the position to 9,724 shares worth $2.45M. The position accounts for 0.21% of the portfolio, ranked #55.

Focused Wealth Management first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Focused Wealth Management held 9,724 shares of AbbVie worth $2.45M as of Q2 2026.
  • Focused Wealth Management bought 362 AbbVie shares in Q2 2026, an estimated $77.9K.
  • AbbVie made up 0.21% of Focused Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Focused Wealth Management first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.